Exogen Registry Data "Minimally Acceptable" For SAFHS Medicare Coverage
This article was originally published in The Gray Sheet
Executive Summary
Exogen's registry data and several well-controlled foreign studies were sufficient for the Health Care Financing Administration to approve the firm's request for national Medicare coverage for the Sonic Accelerated Fracture Healing System (SAFHS).
You may also be interested in...
Exogen Avoids Lengthy MCAC Process In HCFA Coverage Review
The Health Care Financing Administration plans to develop a national Medicare coverage decision for Exogen's Sonic Accelerated Fracture Healing System (SAFHS) without bringing the issue before the Medicare Coverage Advisory Committee, agency staffers report.
Smith & Nephew Exogen 2000 Labeling For Non-Union Fracture Approved
Smith & Nephew will employ its 300-person direct sales force to promote an expanded indication for the Exogen 2000 low-intensity pulsed ultrasound device for treatment of non-union bone fractures, a market valued at roughly $110 mil.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.